LivingGLP1
Study S002739

Therapeutic Drug Use in Patients With Chronic Kidney Disease (CKD): a Multicenter Retrospective Real-world Study

ClinicalTrials.gov record

Registration

Registration
NCT05818995
Study type
OBSERVATIONAL
Status
UNKNOWN
Enrollment
10000
Start
2022-07-01
Primary completion
2024-05-31
Lead sponsor
Qianfoshan Hospital
Conditions
Chronic Kidney Disease
Interventions
DRUG:angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
Results posted
FALSE

Registered primary outcomes

  • eGFR [October , 2023]
  • albuminuria [October , 2023]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.